Pacira BioSciences reported preliminary net product sales of $50.2 million for July 2022. EXPAREL sales grew, and ZILRETTA continued to perform well in its early growth stage. The company is not providing 2022 revenue or gross margin guidance at this time given the continued uncertainty around labor shortages, COVID-19, and the pace of recovery for the elective surgery market.
Net product sales for July 2022 were $50.2 million.
EXPAREL net product sales were $40.9 million, with average daily sales 105 percent of July 2021.
ZILRETTA net product sales were $8.2 million for July 2022.
iovera° net product sales were $1.1 million for July 2022.
The company is not providing 2022 revenue or gross margin guidance at this time given the continued uncertainty around labor shortages, COVID-19, and the pace of recovery for the elective surgery market.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance